[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100607165":3},{"organization":4,"outcomesModule":7,"designInfo":60,"detailedDescription":22,"studyPopulation":22,"armGroups":71,"interventions":90,"overallOfficials":22,"centralContacts":99,"locations":106,"responsibleParty":540,"collaborators":542,"id":545,"slug":546,"hasResults":547,"nctId":548,"briefTitle":549,"officialTitle":550,"acronym":551,"eligibilityCriteria":552,"healthyVolunteers":547,"sex":553,"minAge":554,"maxAge":555,"enrollmentInfo":556,"targetDuration":22,"studyType":559,"phases":560,"briefSummary":562,"conditions":563,"keywords":22,"overallStatus":109,"whyStopped":22,"lastUpdateSubmitDate":565,"lastUpdatePostDateStruct":566,"startDateStruct":569,"completionDateStruct":571,"leadSponsor":573,"locationsCount":574},{"fullName":5,"class":6},"Sanofi","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":13,"otherOutcomes":22},[9],{"measure":10,"description":11,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants achieving clinical remission by modified Mayo Score (mMS).","Mayo Score is a composite index designed to measure UC disease activity. The score ranges from 0 to 9 with higher scores indicating greater disease severity. Clinical remission is defined as mMS score of 0 to 2, including SFS of 0 or 1, RBS of 0, and mMES of 0 or 1 (score of 1 modified to exclude friability)","Week 40",[14,17,20,23,26,30,33,36,39,42,45,48,50,53,55,57],{"measure":15,"description":16,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants with endoscopic improvement.","Endoscopic improvement is defined as mMES of 0 or 1 (score of 1 excludes friability).\n\nEndoscopies were assessed by a blinded central reader and scored according to the following scale: 0 = Normal or inactive disease; 1 = Mild disease (erythema, decreased vascular pattern); 2 = Moderate disease (marked erythema, lack of vascular pattern, any friability, erosions); 3 = Severe disease (spontaneous bleeding, ulceration).",{"measure":18,"description":19,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants achieving histologic endoscopic mucosal improvement.","Histological endoscopic mucosal improvement is defined as MES of 0 or 1 without the evidence of friability and Geboes Score ≤3.1.\n\nThe Geboes score has 6 grades: Grade 0, structural change only; Grade 1, chronic inflammation; Grade 2, lamina propria neutrophils and eosinophils; Grade 3, neutrophils in epithelium; Grade 4, crypt destruction; and Grade 5, erosions or ulceration.",{"measure":21,"description":22,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants with corticosteroid-free clinical remission.",null,{"measure":24,"description":25,"timeFrame":12},"Proportion of participants with no bowel urgency.","The NRS for bowel urgency is a patient-reported tool designed to measure the severity of bowel urgency-the sudden or immediate need to have a bowel movement-experienced in the past 24 hours. This tool utilizes an 11-point scale for evaluation, where 0 represents \"no urgency\" and 10 signifies the \"worst possible urgency\".",{"measure":27,"description":28,"timeFrame":29},"Pivotal Maintenance Sub-Study Cohort 1: Change from Baseline in PROMIS-Fatigue Short Form 7a T-score.","The PROMIS Fatigue Short Form 7a uses a 5-point Likert scale for each of its 7 items, resulting in a raw score range of 7 to 35. This raw score is then converted into a T-score, with a mean of 50 and a standard deviation of 10, based on US national norms. Higher Tscores indicate greater fatigue.","Baseline, Week 40",{"measure":31,"description":32,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants with endoscopic remission.","Endoscopic remission is defined as mMES of 0.",{"measure":34,"description":35,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants achieving clinical remission by mMS, in the subset of participants who achieved clinical remission by mMs at the end of induction period (maintenance of clinical remission).","Clinical response is defined as a decrease from baseline in the mMS of ≥2 points and at least a 30% reduction from baseline, and a decrease in RB subscore of ≥1 or an absolute RB subscore of 0 or 1.\n\nMayo Score is a composite index designed to measure UC disease activity. The score ranges from 0 to 9 with higher scores indicating greater disease severity.",{"measure":37,"description":38,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants with no abdominal pain by Numerical Rating Scale (NRS).","The abdominal pain NRS is a tool to rate the severity of abdominal pain over the past 24 hours using a score of 0 (\"no pain\") to 10 (\"worst possible pain\").",{"measure":40,"description":41,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Change from baseline in Inflammatory Bowel Disease Questionnaire (IBDQ) total score","IBDQ is a tool to the quality of life of individuals suffering from IBD. The total score ranges from 32 to 224, with higher scores correlating to a better quality of life.",{"measure":43,"description":22,"timeFrame":44},"Pivotal Maintenance Sub-Study Cohort 1: Incidence of UC-related hospitalizations.","Week 0 through Week 40",{"measure":46,"description":47,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants with symptomatic (stool-frequency sub score [SFS] and = rectal bleeding sub score [RBS]) remission.","Symptomatic response is defined as ≥30% decrease from baseline in the composite clinical endpoint of the sum of SFS and RBS.",{"measure":49,"description":22,"timeFrame":12},"Pivotal Maintenance Sub-Study Cohort 1: Proportion of participants achieving clinical remission and no steroid use from the baseline to the time of endpoint analysis.",{"measure":51,"description":22,"timeFrame":52},"Pivotal Maintenance Sub-Study Cohort 1: Incidence of Treatment-Emergent Adverse Events (TEAEs), TEAEs of Special Interest, Treatment-Emergent Serious Adverse Events (TESAEs), and TEAEs leading to permanent study intervention discontinuation.","Week 0 through 45 days after last dose",{"measure":54,"description":22,"timeFrame":44},"Pivotal Maintenance Sub-Study Cohort 1: Serum concentration of duvakitug measured over time.",{"measure":56,"description":22,"timeFrame":44},"Pivotal Maintenance Sub-Study Cohort 1: Incidence of treatment-emergent Anti-Drug Antibodies (ADA) against duvakitug.",{"measure":58,"description":22,"timeFrame":59},"Open-Label Extension Sub-Study: Incidence of Treatment-Emergent Adverse Events (TEAEs), TEAEs of Special Interest, Treatment-Emergent Serious Adverse Events (TESAEs), and TEAEs leading to permanent study intervention discontinuation.","Week 40 of pivotal maintenance through 45 days after last dose",{"allocation":61,"interventionModel":62,"interventionModelDescription":22,"primaryPurpose":63,"observationalModel":22,"timePerspective":22,"maskingInfo":64},"RANDOMIZED","PARALLEL","TREATMENT",{"masking":65,"maskingDescription":22,"whoMasked":66},"QUADRUPLE",[67,68,69,70],"PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR",[72,78,82,85],{"label":73,"type":74,"description":75,"interventionNames":76},"Duvakitug - dose 1","EXPERIMENTAL","Subcutaneous (SC) injection as per protocol",[77],"Drug: Duvakitug",{"label":79,"type":74,"description":80,"interventionNames":81},"Duvakitug - dose 2","SC injection as per protocol",[77],{"label":83,"type":74,"description":80,"interventionNames":84},"Duvakitug - dose 3",[77],{"label":86,"type":87,"description":80,"interventionNames":88},"Placebo","PLACEBO_COMPARATOR",[89],"Drug: Placebo",[91,96],{"type":92,"name":93,"description":94,"armGroupLabels":95,"otherNames":22},"DRUG","Duvakitug","Pharmaceutical form: Injection solution Route of administration: SC injection",[73,79,83],{"type":92,"name":86,"description":97,"armGroupLabels":98,"otherNames":22},"Pharmaceutical form:Injection solution-Route of administration:SC injection",[86],[100],{"name":101,"role":102,"phone":103,"phoneExt":104,"email":105},"Trial Transparency email recommended (Toll free for US & Canada)","CONTACT","800-633-1610","option 6","contact-us@sanofi.com",[107,121,131,140,149,159,169,178,187,196,206,216,225,234,244,254,263,273,281,287,297,307,313,322,332,341,350,359,369,381,390,401,412,421,430,439,448,457,468,479,490,496,507,513,522,531],{"facility":108,"status":109,"city":110,"state":111,"zip":112,"country":113,"countryCode":114,"cosmosGeoPoint":115,"geoPoint":120,"contacts":22},"Del Sol Research Management, LLC - Site Number: 8400012","RECRUITING","Tucson","Arizona","85715","United States","US",{"type":116,"coordinates":117},"Point",[118,119],-110.92648,32.22174,{"lat":119,"lon":118},{"facility":122,"status":109,"city":123,"state":124,"zip":125,"country":113,"countryCode":114,"cosmosGeoPoint":126,"geoPoint":130,"contacts":22},"Southern California GI & Liver Centers - Site Number: 8400062","Coronado","California","92118",{"type":116,"coordinates":127},[128,129],-117.18309,32.68589,{"lat":129,"lon":128},{"facility":132,"status":109,"city":133,"state":124,"zip":134,"country":113,"countryCode":114,"cosmosGeoPoint":135,"geoPoint":139,"contacts":22},"United Medical Doctors CA - Site Number: 8400044","Murrieta","92563",{"type":116,"coordinates":136},[137,138],-117.21392,33.55391,{"lat":138,"lon":137},{"facility":141,"status":109,"city":142,"state":124,"zip":143,"country":113,"countryCode":114,"cosmosGeoPoint":144,"geoPoint":148,"contacts":22},"Om Research, LLC - Victorville - Site Number: 8400022","Victorville","92395",{"type":116,"coordinates":145},[146,147],-117.29116,34.53611,{"lat":147,"lon":146},{"facility":150,"status":109,"city":151,"state":152,"zip":153,"country":113,"countryCode":114,"cosmosGeoPoint":154,"geoPoint":158,"contacts":22},"Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039","Colorado Springs","Colorado","80907",{"type":116,"coordinates":155},[156,157],-104.82136,38.83388,{"lat":157,"lon":156},{"facility":160,"status":109,"city":161,"state":162,"zip":163,"country":113,"countryCode":114,"cosmosGeoPoint":164,"geoPoint":168,"contacts":22},"Royal Palm Clinical Research - Site Number: 8400065","Fort Myers","Florida","33901",{"type":116,"coordinates":165},[166,167],-81.84059,26.62168,{"lat":167,"lon":166},{"facility":170,"status":109,"city":171,"state":162,"zip":172,"country":113,"countryCode":114,"cosmosGeoPoint":173,"geoPoint":177,"contacts":22},"Clinical Research of Osceola - Site Number: 8400013","Kissimmee","34741",{"type":116,"coordinates":174},[175,176],-81.41667,28.30468,{"lat":176,"lon":175},{"facility":179,"status":109,"city":180,"state":162,"zip":181,"country":113,"countryCode":114,"cosmosGeoPoint":182,"geoPoint":186,"contacts":22},"Bioresearch Partner-Kendale Lakes - Site Number: 8400053","Miami","33155",{"type":116,"coordinates":183},[184,185],-80.19366,25.77427,{"lat":185,"lon":184},{"facility":188,"status":109,"city":189,"state":162,"zip":190,"country":113,"countryCode":114,"cosmosGeoPoint":191,"geoPoint":195,"contacts":22},"NMC Research LLC - Site Number: 8400033","Tampa","33607",{"type":116,"coordinates":192},[193,194],-82.45843,27.94752,{"lat":194,"lon":193},{"facility":197,"status":109,"city":198,"state":199,"zip":200,"country":113,"countryCode":114,"cosmosGeoPoint":201,"geoPoint":205,"contacts":22},"Gastroenterology Health Partners, PLLC - New Albany - Site Number: 8400100","New Albany","Indiana","47150",{"type":116,"coordinates":202},[203,204],-85.82413,38.28562,{"lat":204,"lon":203},{"facility":207,"status":109,"city":208,"state":209,"zip":210,"country":113,"countryCode":114,"cosmosGeoPoint":211,"geoPoint":215,"contacts":22},"GI Alliance - Baton Rouge - Site Number: 8400129","Baton Rouge","Louisiana","70809",{"type":116,"coordinates":212},[213,214],-91.18747,30.44332,{"lat":214,"lon":213},{"facility":217,"status":109,"city":218,"state":209,"zip":219,"country":113,"countryCode":114,"cosmosGeoPoint":220,"geoPoint":224,"contacts":22},"Texas Digestive Disease Consultants, PLLC d\u002Fb\u002Fa GI Alliance - Mandeville - Site Number: 8400128","Mandeville","70471",{"type":116,"coordinates":221},[222,223],-90.06563,30.35825,{"lat":223,"lon":222},{"facility":226,"status":109,"city":227,"state":209,"zip":228,"country":113,"countryCode":114,"cosmosGeoPoint":229,"geoPoint":233,"contacts":22},"Delta Research Partners - Site Number: 8400087","Monroe","71291",{"type":116,"coordinates":230},[231,232],-92.1193,32.50931,{"lat":232,"lon":231},{"facility":235,"status":109,"city":236,"state":237,"zip":238,"country":113,"countryCode":114,"cosmosGeoPoint":239,"geoPoint":243,"contacts":22},"Gastroenterology Associates of Western Michigan - Site Number: 8400060","Wyoming","Michigan","49519",{"type":116,"coordinates":240},[241,242],-85.70531,42.91336,{"lat":242,"lon":241},{"facility":245,"status":109,"city":246,"state":247,"zip":248,"country":113,"countryCode":114,"cosmosGeoPoint":249,"geoPoint":253,"contacts":22},"Gateway Gastroenterology - Site Number: 8400097","Chesterfield","Missouri","63017",{"type":116,"coordinates":250},[251,252],-90.57707,38.66311,{"lat":252,"lon":251},{"facility":255,"status":109,"city":256,"state":247,"zip":257,"country":113,"countryCode":114,"cosmosGeoPoint":258,"geoPoint":262,"contacts":22},"BVL Clinical Research - Site Number: 8400005","Liberty","64068",{"type":116,"coordinates":259},[260,261],-94.41912,39.24611,{"lat":261,"lon":260},{"facility":264,"status":109,"city":265,"state":266,"zip":267,"country":113,"countryCode":114,"cosmosGeoPoint":268,"geoPoint":272,"contacts":22},"MedTraits NY - Site Number: 8400045","Maspeth","New York","11378",{"type":116,"coordinates":269},[270,271],-73.91264,40.72316,{"lat":271,"lon":270},{"facility":274,"status":109,"city":266,"state":266,"zip":275,"country":113,"countryCode":114,"cosmosGeoPoint":276,"geoPoint":280,"contacts":22},"Weill Cornell Medicine - NewYork-Presbyterian Hospital - Site Number: 8400040","10065",{"type":116,"coordinates":277},[278,279],-74.00597,40.71427,{"lat":279,"lon":278},{"facility":282,"status":109,"city":266,"state":266,"zip":283,"country":113,"countryCode":114,"cosmosGeoPoint":284,"geoPoint":286,"contacts":22},"New York Gastroenterology Associates - Site Number: 8400009","10075",{"type":116,"coordinates":285},[278,279],{"lat":279,"lon":278},{"facility":288,"status":109,"city":289,"state":290,"zip":291,"country":113,"countryCode":114,"cosmosGeoPoint":292,"geoPoint":296,"contacts":22},"Cross Creek Medical Clinic - Site Number: 8400057","Fayetteville","North Carolina","28304",{"type":116,"coordinates":293},[294,295],-78.87836,35.05266,{"lat":295,"lon":294},{"facility":298,"status":109,"city":299,"state":300,"zip":301,"country":113,"countryCode":114,"cosmosGeoPoint":302,"geoPoint":306,"contacts":22},"Ohio Gastroenterology Group Inc. - Site Number: 8400006","Columbus","Ohio","43202",{"type":116,"coordinates":303},[304,305],-82.99879,39.96118,{"lat":305,"lon":304},{"facility":308,"status":109,"city":299,"state":300,"zip":309,"country":113,"countryCode":114,"cosmosGeoPoint":310,"geoPoint":312,"contacts":22},"OSU Wexner Medical Center - Site Number: 8400077","43210",{"type":116,"coordinates":311},[304,305],{"lat":305,"lon":304},{"facility":314,"status":109,"city":315,"state":300,"zip":316,"country":113,"countryCode":114,"cosmosGeoPoint":317,"geoPoint":321,"contacts":22},"North Shore Gastroenterology Research - Site Number: 8400130","Westlake","44145",{"type":116,"coordinates":318},[319,320],-81.91792,41.45532,{"lat":320,"lon":319},{"facility":323,"status":109,"city":324,"state":325,"zip":326,"country":113,"countryCode":114,"cosmosGeoPoint":327,"geoPoint":331,"contacts":22},"GI Alliance - Lubbock - Site Number: 8400092","Lubbock","Texas","79410",{"type":116,"coordinates":328},[329,330],-101.85517,33.57786,{"lat":330,"lon":329},{"facility":333,"status":109,"city":334,"state":325,"zip":335,"country":113,"countryCode":114,"cosmosGeoPoint":336,"geoPoint":340,"contacts":22},"Gastroenterology Research of San Antonio LLC - Site Number: 8400054","San Antonio","78229",{"type":116,"coordinates":337},[338,339],-98.49363,29.42412,{"lat":339,"lon":338},{"facility":342,"status":109,"city":343,"state":325,"zip":344,"country":113,"countryCode":114,"cosmosGeoPoint":345,"geoPoint":349,"contacts":22},"Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101","Southlake","76092",{"type":116,"coordinates":346},[347,348],-97.13418,32.94124,{"lat":348,"lon":347},{"facility":351,"status":109,"city":352,"state":325,"zip":353,"country":113,"countryCode":114,"cosmosGeoPoint":354,"geoPoint":358,"contacts":22},"Tyler Research Institute, LLC - Site Number: 8400095","Tyler","75701",{"type":116,"coordinates":355},[356,357],-95.30106,32.35126,{"lat":357,"lon":356},{"facility":360,"status":109,"city":361,"state":362,"zip":363,"country":113,"countryCode":114,"cosmosGeoPoint":364,"geoPoint":368,"contacts":22},"The Vancouver Clinic Inc. P.S. - Site Number: 8400090","Vancouver","Washington","98664",{"type":116,"coordinates":365},[366,367],-122.66149,45.63873,{"lat":367,"lon":366},{"facility":370,"status":109,"city":371,"state":372,"zip":373,"country":374,"countryCode":375,"cosmosGeoPoint":376,"geoPoint":380,"contacts":22},"Investigational Site Number : 1240003","Toronto","Ontario","M6A 3B4","Canada","CA",{"type":116,"coordinates":377},[378,379],-79.39864,43.70643,{"lat":379,"lon":378},{"facility":382,"status":109,"city":383,"state":22,"zip":384,"country":374,"countryCode":375,"cosmosGeoPoint":385,"geoPoint":389,"contacts":22},"Charlton Digestive Disease Centre - Site Number : 1240009","Hamilton","L8N 1Y2",{"type":116,"coordinates":386},[387,388],-79.84963,43.25011,{"lat":388,"lon":387},{"facility":391,"status":109,"city":392,"state":22,"zip":393,"country":394,"countryCode":395,"cosmosGeoPoint":396,"geoPoint":400,"contacts":22},"Malkhaz Katsiashvili Multiprofile Emergency Medicine Center LLC - Site Number : 2680002","Tbilisi","0180","Georgia","GE",{"type":116,"coordinates":397},[398,399],44.83412,41.69143,{"lat":399,"lon":398},{"facility":402,"status":109,"city":403,"state":22,"zip":404,"country":405,"countryCode":406,"cosmosGeoPoint":407,"geoPoint":411,"contacts":22},"Tokai University Hachioji Hospital - Site Number : 3920031","Hachiōji","192-0032","Japan","JP",{"type":116,"coordinates":408},[409,410],139.32389,35.65583,{"lat":410,"lon":409},{"facility":413,"status":109,"city":414,"state":22,"zip":415,"country":405,"countryCode":406,"cosmosGeoPoint":416,"geoPoint":420,"contacts":22},"Investigational Site Number : 3920049","Kagoshima","892-0843",{"type":116,"coordinates":417},[418,419],130.55,31.56667,{"lat":419,"lon":418},{"facility":422,"status":109,"city":423,"state":22,"zip":424,"country":405,"countryCode":406,"cosmosGeoPoint":425,"geoPoint":429,"contacts":22},"Investigational Site Number : 3920030","Kamakura","247-0056",{"type":116,"coordinates":426},[427,428],139.54698,35.31085,{"lat":428,"lon":427},{"facility":431,"status":109,"city":432,"state":22,"zip":433,"country":405,"countryCode":406,"cosmosGeoPoint":434,"geoPoint":438,"contacts":22},"Investigational Site Number : 3920019","Kobe","650-0015",{"type":116,"coordinates":435},[436,437],135.183,34.6913,{"lat":437,"lon":436},{"facility":440,"status":109,"city":441,"state":22,"zip":442,"country":405,"countryCode":406,"cosmosGeoPoint":443,"geoPoint":447,"contacts":22},"Investigational Site Number : 3920029","Sapporo","004-0041",{"type":116,"coordinates":444},[445,446],141.35,43.06667,{"lat":446,"lon":445},{"facility":449,"status":109,"city":450,"state":22,"zip":451,"country":405,"countryCode":406,"cosmosGeoPoint":452,"geoPoint":456,"contacts":22},"Investigational Site Number : 3920009","Tsu","514-8507",{"type":116,"coordinates":453},[454,455],136.51667,34.73333,{"lat":455,"lon":454},{"facility":458,"status":109,"city":459,"state":22,"zip":460,"country":461,"countryCode":462,"cosmosGeoPoint":463,"geoPoint":467,"contacts":22},"Investigational Site Number : 4400002","Panevezys","35144","Lithuania","LT",{"type":116,"coordinates":464},[465,466],24.35983,55.73186,{"lat":466,"lon":465},{"facility":469,"status":109,"city":470,"state":22,"zip":471,"country":472,"countryCode":473,"cosmosGeoPoint":474,"geoPoint":478,"contacts":22},"SONOMED - Site Number : 6160020","Szczecin","71-685","Poland","PL",{"type":116,"coordinates":475},[476,477],14.55302,53.42894,{"lat":477,"lon":476},{"facility":480,"status":109,"city":481,"state":22,"zip":482,"country":483,"countryCode":484,"cosmosGeoPoint":485,"geoPoint":489,"contacts":22},"Investigational Site Number : 6880001","Belgrade","11,000","Serbia","RS",{"type":116,"coordinates":486},[487,488],20.46513,44.80401,{"lat":488,"lon":487},{"facility":491,"status":109,"city":481,"state":22,"zip":492,"country":483,"countryCode":484,"cosmosGeoPoint":493,"geoPoint":495,"contacts":22},"Investigational Site Number : 6880002","11000",{"type":116,"coordinates":494},[487,488],{"lat":488,"lon":487},{"facility":497,"status":109,"city":498,"state":22,"zip":499,"country":500,"countryCode":501,"cosmosGeoPoint":502,"geoPoint":506,"contacts":22},"Investigational Site Number : 8040001","Kyiv","2002","Ukraine","UA",{"type":116,"coordinates":503},[504,505],30.5238,50.45466,{"lat":505,"lon":504},{"facility":508,"status":109,"city":498,"state":22,"zip":509,"country":500,"countryCode":501,"cosmosGeoPoint":510,"geoPoint":512,"contacts":22},"Investigational Site Number : 8040002","3037",{"type":116,"coordinates":511},[504,505],{"lat":505,"lon":504},{"facility":514,"status":109,"city":515,"state":22,"zip":516,"country":500,"countryCode":501,"cosmosGeoPoint":517,"geoPoint":521,"contacts":22},"Investigational Site Number : 8040005","Lviv","79019",{"type":116,"coordinates":518},[519,520],24.02324,49.83826,{"lat":520,"lon":519},{"facility":523,"status":109,"city":524,"state":22,"zip":525,"country":500,"countryCode":501,"cosmosGeoPoint":526,"geoPoint":530,"contacts":22},"Investigational Site Number : 8040006","Uzhhorod","88018",{"type":116,"coordinates":527},[528,529],22.2947,48.6242,{"lat":529,"lon":528},{"facility":532,"status":109,"city":533,"state":22,"zip":534,"country":500,"countryCode":501,"cosmosGeoPoint":535,"geoPoint":539,"contacts":22},"Investigational Site Number : 8040008","Vinnytsia","21029",{"type":116,"coordinates":536},[537,538],28.46871,49.2322,{"lat":538,"lon":537},{"type":541,"investigatorFullName":22,"investigatorTitle":22,"investigatorAffiliation":22,"oldNameTitle":22,"oldOrganization":22},"SPONSOR",[543],{"name":544,"class":6},"Teva Branded Pharmaceutical Products R&D LLC","100607165","phase-3-a-maintenance-study-to-investigate-the-efficacy-and-safety-of-duvakitug-in-participants-with-moderately-to-severely-active-ulcerative-colitis-100607165",false,"NCT07185009","A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis","A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis","SUNSCAPE-2","Inclusion Criteria:\n\n* Participants aged ≥18 and ≤80 years of age at Baseline. (Where locally permissible, participants 16 to \\\u003C18 years of age who meet the definition of Tanner stage 5 for development)\n* Pivotal Maintenance Sub-Study: Participants who achieved clinical response and completed endoscopy at the end of SUNSCAPE-1\n* OLE Sub-Study: Participants who complete the Pivotal Maintenance Sub-Study or participation in the TV48574-IMM-20038 Study\n\nExclusion Criteria:\n\n* Participants with medical or compliance conditions that are deemed unsuitable for the study by the investigator\n* Participants with a known hypersensitivity to duvakitug that makes the participant unsuitable for the study by the investigator\n\nThe above information is not intended to contain all considerations relevant to a participant's potential participation in a clinical trial.","ALL","16 Years","80 Years",{"count":557,"type":558},751,"ESTIMATED","INTERVENTIONAL",[561],"PHASE3","This is a multicenter, randomized, double-blind, placebo-controlled Phase 3 maintenance study to evaluate the efficacy and safety of duvakitug in participants with moderately to severely active Ulcerative Colitis (UC).\n\nStudy details include:\n\nThe study duration may be up to 286 weeks including:\n\n* 40-week Pivotal Maintenance Sub-Study\n* 240-week Open-Label Extension (OLE) Sub-Study\n* 45-day Follow-up Visit Note: For the participants who do not enroll into OLE Sub-Study, the duration will be up to 46 weeks, including the 40-week maintenance period and a 45-day follow-up visit.\n\nThe treatment duration may be up to 280 weeks including:\n\n* 40 weeks in Pivotal Maintenance Sub-Study\n* 240 weeks in OLE Sub-Study\n\nThe total number of on-site visit will be up to 32:\n\n* 21 visits in the Pivotal Maintenance Sub-Study.\n* 11 visits in the OLE Sub-Study.",[564],"Ulcerative Colitis","2026-08-17",{"date":567,"type":568},"2026-08-18","ACTUAL",{"date":570,"type":568},"2026-01-16",{"date":572,"type":558},"2033-04-28",{"name":5,"class":6},46]